[1] David W. PET/CT:Today and tomorrow[J]. J Nucl Med,2004, 45(1,Suppl):4s-5s.
[2] Burger C, Goerres G, Schoenes S, et al. PET attenuation coefficients from CT images:Experimental evaluation of the transformation of CT into PET 511keV attenuation coefficients[J]. Eur J Nucl Med Mol Imaging, 2002, 29:922-927.
[3] Osman M, Cohade C, Fishman EK, et al. Clinically significant incidental findings on non-contrast CT portion of PET-CT studies:Frequency in 250 patients[J]. J Nucl Med,2002, 43:307P.
[4] Nakamoto Y, Osman M, Cohade C, et al. PET/CT:Comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images[J]. J Nucl Med, 2002, 43:1137-1143.
[5] Cohade C, Osman M, Marshall LT, et al. Metallic objects artifacts on PET-CT:Clinical and phantom studies[J]. J Nucl Med, 2002, 43:308P.
[6] Goerres GW, Hany TF, Kamel E, et al. Head and neck imaging with PET and PET/CT:Artifacts from dental metallic implants[J]. Eur J Nucl Med Mol Imaging, 2002, 29:367-370.
[7] Hany TF, Steinart HC, Goerres GW, et al. PET diagnostic accuracy with in-line PET-CT system[J]. Radiology, 2002,225:575-581.
[8] Luc Boucher. Respiratory gating for 3-dimensional PET of the thorax:feasibility and initial results[J]. J Nucl Med,2004, 45(2):214-219.
[9] Kluetz PG, Meltzer CC, Villemagne VL, et al. Combined PET/CT imaging in oncology:Impact on patient Management[J]. Clin Positron Imaging, 2000, 3:223-230.
[10] Bayer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology[J]. J Nucl Med, 2000, 41:1369-1379.
[11] Goerres GW, Von Schulthess GK, Hany TF. Positron emission tomography and PET/CT of the head and neck:FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment[J]. Am J Roentgenol,2002, 179:1337-1343.
[12] Kamel EM, Goerres GW, Burger C, et al. Recurrent laryngeal nerve palsy in patients with lung cancer:Detection with PET-CT image fusion-report of six cases[J]. Radiology, 2002, 224:153-156.
[13] Cohade C. Uptake in supraclavicular area fat:description on 18F-FDG PET/CT[J]. J Nucl Med, 2003, 44:170-176.
[14] Heller MT, Meltzer CC, Fukui MB, et al. Superphysiologic FDG uptake in the non-paralyzed vocal cord. Resolution of a false-positive PET result with combined PET-CT imaging[J]. Clin Positron Imaging, 2000, 3:207-211.
[15] Osman M, Cohade C, Leal J, et al. Direct comparison of FDG-PET and PET-CT imaging in staging and restaging patients with lung cancer[J]. J Nucl Med, 2002, 43:151P.
[16] Keidar Z. Hybrid imaging using PET/CT with F-18-FDG in suspected recurrence of lung cancer:Diagnostic value and impact on patient management[J]. J Nucl Med, 2002,43(Suppl):A-114.
[17] Steinert H. Impact of integrated PET/CT imaging on preoperative staging of lung cancer patients[J]. J Nucl Med,2002, 43(Suppl):A-547.
[18] Cohade C, Osman M, Leal J, et al. Direct comparison of FDG PET and PET-CT imaging in colorectal cancer[J]. J Nucl Med, 2002, 43:22P.
[19] Makhija S, Howden N, Edwards R, et al. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma:A retrospective review[J]. Gynecol Oncol, 2002, 85:53-58.
[20] Dizendorf E. Impact of integrated PET/CT scanning ion external beam radiation treatment planning[J]. J Nucl Med.2002, 43(Suppl):A-118.
[21] Jeffrey D. Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer[J]. J Nucl Med, 2004, 45:96s-101s.